Clinical Trials Directory

Trials / Sponsors / Metsera, a wholly owned subsidiary of Pfizer

Metsera, a wholly owned subsidiary of Pfizer

Industry · 7 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingEfficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Obesity and Overweight
Phase 32025-12-29
Active Not RecruitingA Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweig
Obesity, Overweight or Obesity
Phase 22025-04-01
CompletedA Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2D
Obesity in Diabetes, Type 2 Diabetes Mellitus (T2DM)
Phase 22025-03-14
RecruitingA Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabete
Obesity and Obesity-related Medical Conditions
Phase 1 / Phase 22025-03-03
Active Not RecruitingA Study of MET233 in Individuals With Obesity or Overweight
Obesity and Overweight
Phase 1 / Phase 22024-11-20
Active Not RecruitingA Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or Overweight
Obesity, Overweight or Obesity
Phase 22024-10-24
CompletedThis Study Will Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MET097 in Adult Partic
Obesity and Overweight
Phase 1 / Phase 22024-04-01